Home  >  News
Msc_Apr23 .
you can get e-magazine links on WhatsApp. Click here
  Ono inks collaboration with Adimab to discover novel antibody drugs in oncology field,   September 28, 2023
  UKHSA announces new UK-based vaccine deal to boost pandemic preparedness against influenza,   September 28, 2023
  Alfasigma to buy Intercept Pharma for $19 per share in cash,   September 28, 2023
  China NMPA approves AffaMed Therapeutics’ clinical trial application for risuteganib for the treatment of intermediate dry AMD,   September 27, 2023
  Sirius Medical collaborates with GE HealthCare to showcase the Pintuition and CEM combination for an efficient and accurate breast cancer care pathway,   September 27, 2023
  Karkinos Healthcare sweeps top honours at Arogya Manthan 2023 for significant contribution to ABDM,   September 27, 2023
  US FDA grants fast track designation to Mythic Therapeutics’ MYTX-011 for patients with NSCLC with cMET overexpression,   September 27, 2023
  Kyverna, ElevateBio partner to advance development and manufacturing of Ingenui-T-derived CAR T-cell therapies,   September 27, 2023
  Sun Pharma introduces Winlevi, a novel topical treatment for acne in Canada,   September 27, 2023
  Mylab Discovery Solutions set to transform new-born screening with its point-of-care solution,   September 27, 2023
  FIP policy statement gives added attention to pharmacy’s value in life-course vaccination,   September 27, 2023
  Panbela gets Chinese patent for claims of a novel process for the production of SBP-101, developed in collaboration with Syngene International,   September 27, 2023
  Biora Therapeutics submits IND application to US FDA for BT-600 programme to treat moderate to severe ulcerative colitis,   September 27, 2023
  Ascletis completes patient enrolment in phase III trial of FASN inhibitor ASC40 combined with bevacizumab to treat recurrent glioblastoma,   September 27, 2023
  Glenmark to market Cosmo Pharma’s Winlevi in 15 EU countries South Africa,   September 27, 2023
  Strides announces ‘OneSource’, an independent specialty pharma CDMO, listing expected in next 12 to 15 months,   September 27, 2023
  Beactica Therapeutics collaborates with NCATS to focus on translation of novel proteolysis-targeting degraders of TEAD to treat cancer,   September 27, 2023
  US FDA accepts for Priority Review the sBLA for Dupixent to treat eosinophilic esophagitis in children aged 1 to 11,   September 27, 2023
  Sandoz receives European marketing approval for biosimilar Tyruko for multiple sclerosis,   September 27, 2023
  Zucara Therapeutics begins patient dosing in phase 2a ZONE trial,   September 26, 2023

Pharma live expo
Copyright © 2023 Saffron Media Pvt. Ltd |